Pediatric Clinical Pharmacology

The objective of this volume is to give an overview of the present state of the art of pediatric clinical pharmacology including developmental physiology, pediatric-specific pathology, special tools and methods for development of drugs for children (assessment of efficacy, toxicity, long-term safety...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Seyberth, Hannsjörg W. (Editor), Rane, Anders (Editor), Schwab, Matthias (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 2011, 2011
Edition:1st ed. 2011
Series:Handbook of Experimental Pharmacology
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 01865nmm a2200361 u 4500
001 EB000386549
003 EBX01000000000000000239601
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9783642201950 
100 1 |a Seyberth, Hannsjörg W.  |e [editor] 
245 0 0 |a Pediatric Clinical Pharmacology  |h Elektronische Ressource  |c edited by Hannsjörg W. Seyberth, Anders Rane, Matthias Schwab 
250 |a 1st ed. 2011 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 2011, 2011 
300 |a XII, 384 p  |b online resource 
505 0 |a Preface -- Part 1: General Considerations and methodological aspects -- Part 2: Development of pediatric medicines -- Part 3: Specific pediatric pharmacology 
653 |a Pediatrics 
653 |a Pharmacology 
653 |a Laboratory Medicine 
653 |a Laboratory medicine 
653 |a Pediatrics 
653 |a Pharmacology/Toxicology 
700 1 |a Rane, Anders  |e [editor] 
700 1 |a Schwab, Matthias  |e [editor] 
710 2 |a SpringerLink (Online service) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Handbook of Experimental Pharmacology 
856 |u https://doi.org/10.1007/978-3-642-20195-0?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 615 
520 |a The objective of this volume is to give an overview of the present state of the art of pediatric clinical pharmacology including developmental physiology, pediatric-specific pathology, special tools and methods for development of drugs for children (assessment of efficacy, toxicity, long-term safety etc.) as well as regulatory and ethical knowledge and skills. In the future, structural and educational changes have to lead back to a closer cooperation and interaction of pediatrics with (clinical) pharmacology and pharmacy